Prognostic relevance of carbonic anhydrase IX in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study

被引：0
|
作者：
Liao, S. [1 ]
Darcy, K. [2 ]
Randall, L. M. [3 ]
Tian, C. [2 ]
Monk, B. J. [3 ]
Burger, R. A. [4 ]
Fruehauf, J. P. [3 ]
Barrett, R. J. [5 ]
Peters, W. A. [6 ]
Stock, R. J. [7 ]
Stanbridge, E. [8 ]
机构：
[1] St Josephs Hosp, Dept Pathol, Orange, CA USA
[2] Roswell Pk Canc Inst, GOG Stat & Data Ctr, Buffalo, NY 14263 USA
[3] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA
[4] Fox Chase Canc Ctr, Dept Gynecol Oncol, Philadelphia, PA 19111 USA
[5] Piedmont Gynecol Oncol, Winston Salem, NC USA
[6] Pacific Gynecol Specialists, Seattle, WA USA
[7] Eastern Virginia Med Sch, Dept Pathol, Norfolk, VA 23501 USA
[8] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA
来源：
GYNECOLOGIC ONCOLOGY | 2009年 / 112卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
28
引用
收藏
页码：S15 / S16
页数：2
相关论文
共 50 条
  • [21] Racial disparities in recurrence among patients with early-stage endometrial cancer: A Gynecologic Oncology Group study
    Maxwell, G.
    Tian, C.
    Risinger, J. I.
    Hamilton, C.
    Farley, J.
    Barakat, R. R.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S30 - S31
  • [22] A Turkish Gynecologic Oncology Group study of fertility-sparing treatment for early-stage endometrial cancer
    Dursun, Polat
    Erkanli, Serkan
    Guzel, Ahmet Baris
    Gultekin, Murat
    Tarhan, Nefise Cagla
    Altundag, Ozden
    Demirkiran, Fuat
    Bese, Tugan
    Yildirim, Yusuf
    Bozdag, Gurkan
    Yarali, Hakan
    Simsek, Tayyup
    Ozcelik, Bulent
    Ortac, Firat
    Taskin, Salih
    Guvenal, Tevfik
    Ozgul, Nejat
    Haberal, Ali
    Vardar, M. Ali
    Dede, Murat
    Yenen, Mufit
    Altintas, Aytekin
    Arvas, Macit
    Ayhan, Ali
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2012, 119 (03) : 270 - 273
  • [23] The oncological safety of hysteroscopy in the diagnosis of early-stage endometrial cancer: An Israel gynecologic oncology group study
    Namazov, Ahmet
    Gemer, Ofer
    Helpman, Limor
    Hag-Yahia, Nasreen
    Eitan, Ram
    Raban, Oded
    Vaknin, Zvi
    Leytes, Sophia
    Lavie, Ofer
    Amit, Amnon
    Levy, Tally
    Volodarsky, Michael
    Ben Shachar, Inbar
    Atlas, Ilan
    Bruchim, Ilan
    Ben-Arie, Alon
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2019, 243 : 120 - 124
  • [24] THE ONCOLOGICAL SAFETY OF HYSTEROSCOPY IN THE DIAGNOSIS OF EARLY-STAGE ENDOMETRIAL CANCER: AN ISRAEL GYNECOLOGIC ONCOLOGY GROUP STUDY
    Volodarsky, M.
    Namazov, A.
    Gemer, O.
    Helpman, L.
    Hag-Yahia, N.
    Eitan, R.
    Raban, O.
    Vaknin, Z.
    Leytes, S.
    Lavie, O.
    Amit, A.
    Levy, T.
    Ben Shachar, I.
    Atlas, I.
    Bruchim, I.
    Ben-Arie, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A38 - A39
  • [25] The potential benefit of six versus three cycles of chemotherapy in subsets of women with high-risk early-stage epithelial ovarian,cancer: An exploratory analysis of a Gynecologic Oncology Group study
    Chan, J. K.
    Fleming, G.
    Zhang, M.
    Tian, C.
    Kapp, D. S.
    Monk, B. J.
    Herzog, T.
    Bell, J.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S3 - S4
  • [26] RADICAL TRACHELECTOMY FOR EARLY-STAGE CERVICAL CANCER: A SURVEY OF THE SOCIETY OF GYNECOLOGIC ONCOLOGY (SGO) AND GYNECOLOGIC ONCOLOGY FELLOWS-IN-TRAINING
    Churchill, S. J.
    Armbruster, S. D.
    Schmeler, K. M.
    Frumovitz, M.
    Greer, M.
    Garcia, J.
    Redworth, G.
    Ramirez, P. T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 4 - 4
  • [27] Utilization and outcome of systemic chemotherapy for high-risk early-stage cervical cancer.
    Takekuma, Munetaka
    Matsuzaki, Shinya
    Matsuo, Koji
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [28] Chemotherapy for high-risk early-stage endometrial cancer
    Kodama, Junichi
    Seki, Noriko
    Hiramatsu, Yuji
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2007, 19 (01) : 42 - 47
  • [29] ENDOMETRIAL CANCER - THE HIGH-RISK EARLY-STAGE PATIENT
    MORROW, CP
    WESTERN JOURNAL OF MEDICINE, 1990, 153 (01): : 78 - 79
  • [30] The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: An exploratory analysis of a Gynecologic Oncology Group study
    Chan, John K.
    Tian, Chunqiao
    Fleming, Gini F.
    Monk, Bradley J.
    Herzog, Thomas J.
    Kapp, Daniel S.
    Bell, Jeffrey
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : 301 - 306
12345